General Practice/Family Medicine

Amendments to the Pharmacy Act that expand the role of pharmacists come into effect today.

Merck Frosst is introducing a new strength of Fosavance (alendronate sodium/cholecalciferol) that contains a higher amount of cholecalciferol (vitamin D3).

Dr. Robert Ouellet, president of the CMA, today announced the CMA's intention to begin an international fact-finding mission examining ideas for health care reform and renewal in several European countries.

Novartis Consumer Healthcare is introducing the first nonprescription topical nonsteroidal anti-inflammatory drug to be marketed in Canada.

A new section of the Veterans Affairs Canada website reinforces the importance of maintaining good oral health in order to optimize overall health in seniors.

The Canadian Paediatric Society has issued a revised statement on the diagnosis and management of head lice.

Ontario came in first in the Frontier Centre for Public Policy's first annual Canada Health Consumer Index which was released today.

Gilead Sciences' Viread (tenofovir disoproxil fumarate tablets) is now indicated for the treatment of chronic hepatitis B infection in adults.